{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T22:50:29Z","timestamp":1791240629845,"version":"4.1.0"},"reference-count":76,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["R01AR066036"],"award-info":[{"award-number":["R01AR066036"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["F31AR071783"],"award-info":[{"award-number":["F31AR071783"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["1RO1AR075768"],"award-info":[{"award-number":["1RO1AR075768"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["RO1NS109117"],"award-info":[{"award-number":["RO1NS109117"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajp.amjpathol.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Pathology"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.ajpath.2024.12.012","type":"journal-article","created":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T11:26:37Z","timestamp":1736767597000},"page":"717-740","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Cytotoxic T-Lymphocyte\u2013Associated Protein 4 Fused to a Modified Fragment of IgG1 Reduces Muscle Fiber Damage in a Model of Duchenne Muscular Dystrophy by Attenuating Proinflammatory Gene Expression in Myeloid Lineage Cells"],"prefix":"10.1016","volume":"195","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-2228-6255","authenticated-orcid":false,"given":"Michelle","family":"Wehling-Henricks","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su-yin","family":"Kok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-0425-8983","authenticated-orcid":false,"given":"Haley","family":"Gamboa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pranav","family":"Kannan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-5934-8868","authenticated-orcid":false,"given":"Connor","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Flores","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2353-0325","authenticated-orcid":false,"given":"Steven S.","family":"Welc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1202-8038","authenticated-orcid":false,"given":"James G.","family":"Tidball","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajpath.2024.12.012_bib1","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/0092-8674(87)90579-4","article-title":"Dystrophin: the protein product of the Duchenne muscular dystrophy locus","volume":"51","author":"Hoffman","year":"1987","journal-title":"Cell"},{"key":"10.1016\/j.ajpath.2024.12.012_bib2","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/BF01799615","article-title":"The membrane hypothesis of Duchenne muscular dystrophy: quest for functional evidence","volume":"15","author":"Hutter","year":"1992","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.ajpath.2024.12.012_bib3","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1038\/333863a0","article-title":"Immunoelectron microscopic localization of dystrophin in myofibres","volume":"333","author":"Watkins","year":"1988","journal-title":"Nature"},{"key":"10.1016\/j.ajpath.2024.12.012_bib4","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1212\/WNL.25.12.1111","article-title":"Duchenne dystrophy: electron microscopic findings pointing to a basic or early abnormality in the plasma membrane of the muscle fiber","volume":"25","author":"Mokri","year":"1975","journal-title":"Neurology"},{"key":"10.1016\/j.ajpath.2024.12.012_bib5","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1093\/jb\/118.5.959","article-title":"Visualization of dystrophic muscle fibers in mdx mouse by vital staining with Evans blue: evidence of apoptosis in dystrophin-deficient muscle","volume":"118","author":"Matsuda","year":"1995","journal-title":"J Biochem"},{"key":"10.1016\/j.ajpath.2024.12.012_bib6","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1083\/jcb.128.3.355","article-title":"Mechanical function of dystrophin in muscle cells","volume":"128","author":"Pasternak","year":"1995","journal-title":"J Cell Biol"},{"key":"10.1016\/j.ajpath.2024.12.012_bib7","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1083\/jcb.200105110","article-title":"A nitric oxide synthase transgene ameliorates muscular dystrophy in mdx mice","volume":"155","author":"Wehling","year":"2001","journal-title":"J Cell Biol"},{"key":"10.1016\/j.ajpath.2024.12.012_bib8","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1172\/JCI30556","article-title":"Interplay of IKK\/NF-kappaB signaling in macrophages and myofibers promotes muscle degeneration in Duchenne muscular dystrophy","volume":"117","author":"Acharyya","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ajpath.2024.12.012_bib9","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1093\/hmg\/ddu735","article-title":"Toll-like receptor 4 ablation in mdx mice reveals innate immunity as a therapeutic target in Duchenne muscular dystrophy","volume":"24","author":"Giordano","year":"2015","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.ajpath.2024.12.012_bib10","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1006\/clim.2000.4966","article-title":"Helper (CD4(+)) and cytotoxic (CD8(+)) T cells promote the pathology of dystrophin-deficient muscle","volume":"98","author":"Spencer","year":"2001","journal-title":"Clin Immunol"},{"key":"10.1016\/j.ajpath.2024.12.012_bib11","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.nmd.2006.06.011","article-title":"Reduced necrosis of dystrophic muscle by depletion of host neutrophils, or blocking TNFalpha function with etanercept in mdx mice","volume":"16","author":"Hodgetts","year":"2006","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.ajpath.2024.12.012_bib12","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1093\/hmg\/ddn129","article-title":"Major basic protein-1 promotes fibrosis of dystrophic muscle and attenuates the cellular immune response in muscular dystrophy","volume":"17","author":"Wehling-Henricks","year":"2008","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.ajpath.2024.12.012_bib13","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1212\/WNL.0000000000001950","article-title":"Prednisone\/prednisolone and deflazacort regimens in the CINRG Duchenne Natural History Study","volume":"85","author":"Bello","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.ajpath.2024.12.012_bib14","doi-asserted-by":"crossref","first-page":"463","DOI":"10.3233\/JND-210776","article-title":"Comparing deflazacort and prednisone in Duchenne muscular dystrophy","volume":"9","author":"Biggar","year":"2022","journal-title":"J Neuromuscul Dis"},{"key":"10.1016\/j.ajpath.2024.12.012_bib15","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1177\/0883073814558120","article-title":"Corticosteroid treatments in males with Duchenne muscular dystrophy: treatment duration and time to loss of ambulation","volume":"30","author":"Kim","year":"2015","journal-title":"J Child Neurol"},{"key":"10.1016\/j.ajpath.2024.12.012_bib16","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0140-6736(17)32160-8","article-title":"Long-term effects of glucocorticoids on function, quality of life, and survival in patients with Duchenne muscular dystrophy: a prospective cohort study","volume":"391","author":"McDonald","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.ajpath.2024.12.012_bib17","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1056\/NEJM198906153202405","article-title":"Randomized, double-blind six-month trial of prednisone in Duchenne's muscular dystrophy","volume":"320","author":"Mendell","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpath.2024.12.012_bib18","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s00198-003-1443-y","article-title":"Bone mineral density and bone metabolism in Duchenne muscular dystrophy","volume":"14","author":"Bianchi","year":"2003","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.ajpath.2024.12.012_bib19","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.jaapos.2018.01.017","article-title":"Cataract development associated with long-term glucocorticoid therapy in Duchenne muscular dystrophy patients","volume":"22","author":"Rice","year":"2018","journal-title":"J AAPOS"},{"key":"10.1016\/j.ajpath.2024.12.012_bib20","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/00000441-197603000-00009","article-title":"Effects of glucocorticoids on carbohydrate metabolism","volume":"271","author":"Olefsky","year":"1976","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.ajpath.2024.12.012_bib21","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.90341","article-title":"Disease-modifying effects of orally bioavailable NF-[kappa]B inhibitors in dystrophin-deficient muscle","volume":"1","author":"Hammers","year":"2016","journal-title":"JCI Insight"},{"key":"10.1016\/j.ajpath.2024.12.012_bib22","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.nmd.2021.02.001","article-title":"Disease-modifying effects of edasalonexent, an NF-kappaB inhibitor, in young boys with Duchenne muscular dystrophy: results of the MoveDMD phase 2 and open label extension trial","volume":"31","author":"Finkel","year":"2021","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.ajpath.2024.12.012_bib23","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1152\/physrev.00040.2009","article-title":"NF-kappaB signaling: a tale of two pathways in skeletal myogenesis","volume":"90","author":"Bakkar","year":"2010","journal-title":"Physiol Rev"},{"key":"10.1016\/j.ajpath.2024.12.012_bib24","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1056\/NEJMoa050524","article-title":"Abatacept for rheumatoid arthritis refractory to tumor necrosis factor alpha inhibition","volume":"353","author":"Genovese","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpath.2024.12.012_bib25","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0140-6736(08)60998-8","article-title":"Abatacept in children with juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled withdrawal trial","volume":"372","author":"Ruperto","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.ajpath.2024.12.012_bib26","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1084\/jem.174.3.561","article-title":"CTLA-4 is a second receptor for the B cell activation antigen B7","volume":"174","author":"Linsley","year":"1991","journal-title":"J Exp Med"},{"key":"10.1016\/j.ajpath.2024.12.012_bib27","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1126\/science.1496399","article-title":"Immunosuppression in\u00a0vivo by a soluble form of the CTLA-4 T cell activation molecule","volume":"257","author":"Linsley","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.ajpath.2024.12.012_bib28","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1172\/JCI119464","article-title":"Myonuclear apoptosis in dystrophic mdx muscle occurs by perforin-mediated cytotoxicity","volume":"99","author":"Spencer","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ajpath.2024.12.012_bib29","doi-asserted-by":"crossref","first-page":"5419","DOI":"10.4049\/jimmunol.1101267","article-title":"IFN-gamma promotes muscle damage in the mdx mouse model of Duchenne muscular dystrophy by suppressing M2 macrophage activation and inhibiting muscle cell proliferation","volume":"187","author":"Villalta","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.ajpath.2024.12.012_bib30","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1002\/(SICI)1097-4598(199612)19:12<1549::AID-MUS4>3.0.CO;2-A","article-title":"The mdx-amplification-resistant mutation system assay, a simple and rapid polymerase chain reaction-based detection of the mdx allele","volume":"19","author":"Amalfitano","year":"1996","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ajpath.2024.12.012_bib31","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0092-8674(00)80532-2","article-title":"Utrophin-dystrophin-deficient mice as a model for Duchenne muscular dystrophy","volume":"90","author":"Deconinck","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.ajpath.2024.12.012_bib32","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1093\/hmg\/ddq523","article-title":"Interleukin-10 reduces the pathology of mdx muscular dystrophy by deactivating M1 macrophages and modulating macrophage phenotype","volume":"20","author":"Villalta","year":"2011","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.ajpath.2024.12.012_bib33","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.1371\/journal.pcbi.0030039","article-title":"Discovering motifs in ranked lists of DNA sequences","volume":"23","author":"Eden","year":"2007","journal-title":"PLoS Comput Biol"},{"key":"10.1016\/j.ajpath.2024.12.012_bib34","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1471-2105-10-48","article-title":"GOrilla: a tool for discovery and visualization of enriched GO terms in ranked gene lists","volume":"3","author":"Eden","year":"2009","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.ajpath.2024.12.012_bib35","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1096\/fj.03-1024com","article-title":"Anti-TNFalpha (Remicade) therapy protects dystrophic skeletal muscle from necrosis","volume":"18","author":"Grounds","year":"2004","journal-title":"FASEB J"},{"key":"10.1016\/j.ajpath.2024.12.012_bib36","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.nmd.2004.04.008","article-title":"Prednisolone decreases cellular adhesion molecules required for inflammatory cell infiltration in dystrophin-deficient skeletal muscle","volume":"14","author":"Wehling-Henricks","year":"2004","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.ajpath.2024.12.012_bib37","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jneuroim.2013.09.007","article-title":"EPA protects against muscle damage in the mdx mouse model of Duchenne muscular dystrophy by promoting a shift from the M1 to M2 macrophage phenotype","volume":"264","author":"Carvalho","year":"2013","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.ajpath.2024.12.012_bib38","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.cell.2013.10.054","article-title":"A special population of regulatory T cells potentiates muscle repair","volume":"155","author":"Burzyn","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.ajpath.2024.12.012_bib39","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3009925","article-title":"Regulatory T cells suppress muscle inflammation and injury in muscular dystrophy","volume":"6","author":"Villalta","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.ajpath.2024.12.012_bib40","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1016\/j.cca.2011.11.006","article-title":"Surface markers of lymphocyte activation and markers of cell proliferation","volume":"413","author":"Shipkova","year":"2012","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.ajpath.2024.12.012_bib41","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/jlb.67.1.97","article-title":"Regulation of scavenger receptor CD163 expression in human monocytes and macrophages by pro- and antiinflammatory stimuli","volume":"67","author":"Buechler","year":"2000","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.ajpath.2024.12.012_bib42","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.it.2004.09.015","article-title":"The chemokine system in diverse forms of macrophage activation and polarization","volume":"25","author":"Mantovani","year":"2004","journal-title":"Trends Immunol"},{"key":"10.1016\/j.ajpath.2024.12.012_bib43","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1038\/nri1733","article-title":"Monocyte and macrophage heterogeneity","volume":"5","author":"Gordon","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.ajpath.2024.12.012_bib44","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/ni1309","article-title":"Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2","volume":"7","author":"Serbina","year":"2006","journal-title":"Nature Immunol"},{"key":"10.1016\/j.ajpath.2024.12.012_bib45","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1172\/JCI29919","article-title":"Critical roles for CCR2 and MCP-3 in monocyte mobilization from bone marrow and recruitment to inflammatory sites","volume":"117","author":"Tsou","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ajpath.2024.12.012_bib46","doi-asserted-by":"crossref","first-page":"3344","DOI":"10.1096\/fj.10-178939","article-title":"Acute skeletal muscle injury: CCL2 expression by both monocytes and injured muscle is required for repair","volume":"25","author":"Lu","year":"2011","journal-title":"FASEB J"},{"key":"10.1016\/j.ajpath.2024.12.012_bib47","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/nri.2016.150","article-title":"Regulation of muscle growth and regeneration by the immune system","volume":"17","author":"Tidball","year":"2017","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.ajpath.2024.12.012_bib48","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/0040-8166(76)90039-2","article-title":"The morphology of regeneration of skeletal muscles in the rat","volume":"8","author":"Schmalbruch","year":"1976","journal-title":"Tissue Cell"},{"key":"10.1016\/j.ajpath.2024.12.012_bib49","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1152\/physrev.00019.2003","article-title":"Cellular and molecular regulation of muscle regeneration","volume":"84","author":"Charg\u00e9","year":"2004","journal-title":"Physiol Rev"},{"key":"10.1016\/j.ajpath.2024.12.012_bib50","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/s41572-021-00321-x","article-title":"Idiopathic inflammatory myopathies","volume":"7","author":"Lundberg","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.ajpath.2024.12.012_bib51","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/ana.410160207","article-title":"Monoclonal antibody analysis of mononuclear cells in myopathies, II: phenotypes of autoinvasive cells in polymyositis and inclusion body myositis","volume":"16","author":"Engel","year":"1984","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ajpath.2024.12.012_bib52","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1749-6632.2009.05119.x","article-title":"Dermatomyositis and polymyositis: clinical presentation, autoantibodies, and pathogenesis","volume":"1184","author":"Mammen","year":"2010","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.ajpath.2024.12.012_bib53","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1007\/s11926-996-0024-4","article-title":"Pathogenesis of idiopathic inflammatory myopathies","volume":"8","author":"Grundtman","year":"2006","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.ajpath.2024.12.012_bib54","first-page":"593","article-title":"Direct suppression of autoaggressive CD8+ T cells with CD80\/86 blockade in CD8+ T cell-mediated polymyositis models of mice","volume":"35","author":"Hasegawa","year":"2017","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.ajpath.2024.12.012_bib55","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.jbspin.2011.03.022","article-title":"Abatacept for treatment of refractory polymyositis","volume":"78","author":"Musuruana","year":"2011","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.ajpath.2024.12.012_bib56","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s10067-014-2507-4","article-title":"Abatacept as a successful therapy for myositis\u2014a case-based review","volume":"34","author":"Kerola","year":"2015","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.ajpath.2024.12.012_bib57","doi-asserted-by":"crossref","first-page":"618","DOI":"10.46497\/ArchRheumatol.2020.7406","article-title":"A case of refractory polymyositis successfully treated with abatacept monotherapy","volume":"35","author":"\u00c7a\u011flayan","year":"2020","journal-title":"Arch Rheumatol"},{"key":"10.1016\/j.ajpath.2024.12.012_bib58","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1136\/annrheumdis-2017-211751","article-title":"Abatacept in the treatment of adult dermatomyositis and polymyositis: a randomised, phase IIb treatment delayed-start trial","volume":"77","author":"Tj\u00e4rnlund","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ajpath.2024.12.012_bib59","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1002\/art.42450","article-title":"Improvement in disease activity in refractory juvenile dermatomyositis following abatacept therapy","volume":"75","author":"Curiel","year":"2023","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.ajpath.2024.12.012_bib60","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1016\/j.bbamcr.2016.06.003","article-title":"Membrane repair of human skeletal muscle cells requires annexin-A5","volume":"1863","author":"Carmeille","year":"2016","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.ajpath.2024.12.012_bib61","doi-asserted-by":"crossref","first-page":"4226","DOI":"10.1038\/s41598-021-82926-6","article-title":"Timescale of hole closure during plasma membrane repair estimated by calcium imaging and numerical modeling","volume":"11","author":"Klenow","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.ajpath.2024.12.012_bib62","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1002\/mus.26329","article-title":"Evidence of induced muscle regeneration persists for years in the mouse","volume":"58","author":"Meyer","year":"2018","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ajpath.2024.12.012_bib63","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/ajt.16218","article-title":"CTLA4-Ig prolongs graft survival specifically in young but not old mice","volume":"21","author":"Heinbokel","year":"2021","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ajpath.2024.12.012_bib64","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0067709","article-title":"T cell activation inhibitors reduce CD8+ T cell and pro-inflammatory macrophage accumulation in adipose tissue of obese mice","volume":"8","author":"Montes","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ajpath.2024.12.012_bib65","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms14680","article-title":"T cell costimulation blockade blunts pressure overload-induced heart failure","volume":"8","author":"Kallikourdis","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.ajpath.2024.12.012_bib66","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1093\/rheumatology\/kev403","article-title":"Abatacept (CTLA-4Ig) treatment reduces T cell apoptosis and regulatory T cell suppression in patients with rheumatoid arthritis","volume":"55","author":"Bonelli","year":"2016","journal-title":"Rheumatology"},{"key":"10.1016\/j.ajpath.2024.12.012_bib67","doi-asserted-by":"crossref","first-page":"37","DOI":"10.4049\/jimmunol.1002777","article-title":"IDO and regulatory T cell support are critical for cytotoxic T lymphocyte-associated Ag-4 Ig-mediated long-term solid organ allograft survival","volume":"188","author":"Sucher","year":"2012","journal-title":"J Immunol"},{"key":"10.1016\/j.ajpath.2024.12.012_bib68","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1002\/eji.201445190","article-title":"CD28\/CTLA-4\/B7 costimulatory pathway blockade affects regulatory T-cell function in autoimmunity","volume":"45","author":"Vogel","year":"2015","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.ajpath.2024.12.012_bib69","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/nri3070","article-title":"Monocyte recruitment during infection and inflammation","volume":"11","author":"Shi","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.ajpath.2024.12.012_bib70","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1099\/vir.0.041046-0","article-title":"Impact of deficiency in CCR2 and CX3CR1 receptors on monocytes trafficking in herpes simplex virus encephalitis","volume":"93","author":"Boivin","year":"2012","journal-title":"J Gen Virol"},{"key":"10.1016\/j.ajpath.2024.12.012_bib71","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/art.37787","article-title":"Abatacept (CTLA-4IG) treatment reduces the migratory capacity of monocytes in patients with rheumatoid arthritis","volume":"65","author":"Bonelli","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ajpath.2024.12.012_bib72","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1136\/annrheumdis-2011-200348","article-title":"Abatacept modulates proinflammatory macrophage responses upon cytokine-activated T cell and toll-like receptor ligand stimulation","volume":"71","author":"Wenink","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ajpath.2024.12.012_bib73","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s10875-009-9282-z","article-title":"Abatacept does not induce direct gene expression changes in antigen-presenting cells","volume":"29","author":"Carman","year":"2009","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.ajpath.2024.12.012_bib74","first-page":"943","article-title":"Intracellular NF-[kappa]B-decrease and IKB[alpha] increase in human macrophages following CTLA4-Ig treatment","volume":"31","author":"Cutolo","year":"2013","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.ajpath.2024.12.012_bib75","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1002\/art.27183","article-title":"Muscle resident macrophages control the immune cell reaction in a mouse model of notexin-induced myoinjury","volume":"62","author":"Brigitte","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ajpath.2024.12.012_bib76","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1038\/s41467-022-28531-1","article-title":"TLR4 is a regulator of trained immunity in a murine model of Duchenne muscular dystrophy","volume":"13","author":"Bhattarai","year":"2022","journal-title":"Nat Commun"}],"container-title":["The American Journal of Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944025000033?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944025000033?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:48:44Z","timestamp":1775004524000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002944025000033"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":76,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S0002944025000033"],"URL":"https:\/\/doi.org\/10.1016\/j.ajpath.2024.12.012","relation":{},"ISSN":["0002-9440"],"issn-type":[{"value":"0002-9440","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cytotoxic T-Lymphocyte\u2013Associated Protein 4 Fused to a Modified Fragment of IgG1 Reduces Muscle Fiber Damage in a Model of Duchenne Muscular Dystrophy by Attenuating Proinflammatory Gene Expression in Myeloid Lineage Cells","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajpath.2024.12.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Society for Investigative Pathology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}